Works matching AU Stocker, Sophie L.


Results: 68
    1
    2
    3
    4
    5
    6
    7

    Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis.

    Published in:
    Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 212, doi. 10.1002/cpt.2113
    By:
    • Stocker, Sophie L.;
    • Carland, Jane E.;
    • Reuter, Stephanie E.;
    • Stacy, Alexandra E.;
    • Schaffer, Andrea L.;
    • Stefani, Maurizio;
    • Lau, Cindy;
    • Kirubakaran, Ranita;
    • Yang, Jennifer J.;
    • Shen, Catriona F.J.;
    • Roberts, Darren M.;
    • Marriott, Deborah J.E.;
    • Day, Richard O.;
    • Brett, Jonathan
    Publication type:
    Article
    8
    9
    10
    11

    Management of gout in older people.

    Published in:
    Journal of Pharmacy Practice & Research, 2019, v. 49, n. 1, p. 90, doi. 10.1002/jppr.1511
    By:
    • Day, Richard O.;
    • Lau, Wendy;
    • Stocker, Sophie L.;
    • Aung, Eindra;
    • Coleshill, Mathew J.;
    • Schulz, Marcel;
    • Bechara, Jacob;
    • Carland, Jane E.;
    • Graham, Garry G.;
    • Williams, Kenneth M.;
    • McLachlan, Andrew J.
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysis.

    Published in:
    British Journal of Clinical Pharmacology, 2019, v. 85, n. 12, p. 2772, doi. 10.1111/bcp.14107
    By:
    • Abdel Shaheed, Christina;
    • Carland, Jane E.;
    • Graham, Garry G.;
    • Stocker, Sophie L.;
    • Smith, Greg;
    • Hicks, Mark;
    • Williams, Kenneth M.;
    • Furlong, Timothy;
    • Macdonald, Peter;
    • Greenfield, Jerry R.;
    • Smith, Felicity C.;
    • Chowdhury, Gina;
    • Day, Richard O.
    Publication type:
    Article
    34

    Individualising the dose of allopurinol in patients with gout.

    Published in:
    British Journal of Clinical Pharmacology, 2017, v. 83, n. 9, p. 2015, doi. 10.1111/bcp.13307
    By:
    • Kannangara, Diluk R. W.;
    • Graham, Garry G.;
    • Wright, Daniel F. B.;
    • Stocker, Sophie L.;
    • Portek, Ian;
    • Pile, Kevin D.;
    • Barclay, Murray L.;
    • Williams, Kenneth M.;
    • Stamp, Lisa K.;
    • Day, Richard O.
    Publication type:
    Article
    35
    36
    37
    38
    39

    Relative Forgiveness of Different Allopurinol Implementation Patterns in People with Gout and their Impact on Clinical Outcomes: a Simulation Study: Relative Forgiveness of Different Allopurinol Implementation Patterns in People with Gout: M. White-Koning et al

    Published in:
    Clinical Pharmacokinetics, 2025, v. 64, n. 1, p. 93, doi. 10.1007/s40262-024-01467-z
    By:
    • White-Koning, Melanie;
    • Wright, Daniel F. B.;
    • Hughes, Dyfrig A.;
    • Michael, Toni J. F.;
    • Coleshill, Matthew J.;
    • Aslani, Parisa;
    • Day, Richard O.;
    • Stocker, Sophie L.
    Publication type:
    Article
    40
    42
    43
    44
    45
    46
    47
    48
    49
    50